Form 4 for OKYO OKYO Pharma Ltd
Accepted 2023-10-31 00:00:00 ET · period of report 2023-10-23 · accession 0001493152-23-038854 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-10-31 | 2023-10-23+ | OKYO | CERRONE GABRIELE M | Executive COB, Dir | J - Other | $1.50 | +569.5K | 9.11M | +7% | +$854.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-10-27 | J | A | 70,071 | $1.50 | 9,177,903 | I Via Panetta Partners Limited | — | — | |
| 2 | Common | Ordinary Shares | 2023-10-23 | J | A | 499,468 | $1.50 | 9,107,832 | I Via Panetta Partners Limited | — | — |